Skip to main content
Amy Petrin

Amy Petrin

Dr. Julie Petrin — Director, Strategy and Impact at MS Canada, a person living with MS and researcher on healthcare access for Canadians with MS.

Sep 2, 2026

2:09
So I think the first question, I think a very simple question for all three of us might be, what does neurofilament light chain represent for you? Julie, perhaps we could start with you.
2:20
Yeah, for sure.
2:20
So just to give a bit of context, I'm going to be speaking primarily today from my perspective as someone with lived experience, diagnosed when I was 16 years old.
2:32
So I've been living with MS now for over 20 years.
2:36
Just to give a bit of context to anyone listening, And I think why it's important and why we're all here today and why I was happy to join the call today was essentially because you don't get much access to being able to know what's going on in your body.
2:59
Essentially, when you're diagnosed with MS, you're diagnosed with a disease that's very unpredictable.
3:04
You're living with a lot of uncertainty.

8 MINS LATER

11:04
Julie, how about from your perspective, is the attraction to a blood-based biomarker different to what Ron's mentioning there?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.